Σάββατο 27 Οκτωβρίου 2018

[Absorbent products for urinary incontinence management].

CONCLUSION: Comparative analyzes of risk-benefit, economic costs, patient satisfaction, protections vs. other measures are lacking. It is necessary to continue the development of these products and to compare more precisely their intrinsic characteristics, to best support patients choices. PMID: 30361139 [PubMed - as supplied by publisher] (Source: Progres en Urologie)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2yBoNmm

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.